Daniel Kirby
Overview
Explore the profile of Daniel Kirby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kirby D, Glynn M, Kijanka G, Ducree J
Cytometry A
. 2014 Nov;
87(1):74-80.
PMID: 25393340
We present a substantially improved design and functionality of a centrifugo-magnetophoretic platform which integrates direct immunoseparation and cost-efficient, bright-field detection of cancer cells in whole blood. All liquid handling takes...
12.
DiazGranados C, Dunning A, Kimmel M, Kirby D, Treanor J, Collins A, et al.
N Engl J Med
. 2014 Aug;
371(7):635-45.
PMID: 25119609
Background: As compared with a standard-dose vaccine, a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD) improves antibody responses to influenza among adults 65 years of age or older. This study evaluated...
13.
Glynn M, Kirby D, Chung D, Kinahan D, Kijanka G, Ducree J
J Lab Autom
. 2013 Sep;
19(3):285-96.
PMID: 24056858
In medical diagnostics, detection of cells exhibiting specific phenotypes constitutes a paramount challenge. Detection technology must ensure efficient isolation of (often rare) targets while eliminating nontarget background cells. Technologies exist...
14.
Burger R, Kirby D, Glynn M, Nwankire C, OSullivan M, Siegrist J, et al.
Curr Opin Chem Biol
. 2012 Jul;
16(3-4):409-14.
PMID: 22784388
Over the past two decades, centrifugal microfluidic systems have successfully demonstrated their capability for robust, high-performance liquid handling to enable modular, multi-purpose lab-on-a-chip platforms for a wide range of life-science...
15.
Plennevaux E, Blatter M, Cornish M, Go K, Kirby D, Wali M, et al.
Vaccine
. 2011 Jan;
29(8):1569-75.
PMID: 21219979
The goal of this pediatric clinical trial was to assess the safety and immunogenicity of two different doses of a monovalent inactivated pandemic (H1N1) 2009 vaccine in US children aged...
16.
Kirby D, Green S, Palmans H, Hugtenburg R, Wojnecki C, Parker D
Phys Med Biol
. 2009 Dec;
55(2):417-33.
PMID: 20019399
Dosimetry using a PMMA phantom was performed in 15 and 29 MeV proton beams from the Birmingham cyclotron, with a Markus parallel-plate ionization chamber and GafChromic EBT and MD-V2-55 film....
17.
Christensen D, Agger E, Andreasen L, Kirby D, Andersen P, Perrie Y
J Liposome Res
. 2009 Jun;
19(1):2-11.
PMID: 19515003
The use of liposomes as vaccine adjuvants has been investigated extensively over the last few decades. In particular, cationic liposomal adjuvants have drawn attention, with dimethyldioctadecylammonium (DDA) liposomes as a...
18.
Perrie Y, Kirby D, Bramwell V, Mohammed A
Recent Pat Drug Deliv Formul
. 2008 Dec;
1(2):117-29.
PMID: 19075879
Vaccines remain a key tool in the defence against major diseases. However, in the development of vaccines a trade off between safety and efficacy is required with newer vaccines, based...
19.
Christensen D, Kirby D, Foged C, Agger E, Andersen P, Perrie Y, et al.
Biochim Biophys Acta
. 2008 Feb;
1778(5):1365-73.
PMID: 18261458
Trehalose is a well known protector of biostructures like liposomes and proteins during freeze-drying, but still today there is a big debate regarding its mechanism of action. In previous experiments...
20.
Vangala A, Kirby D, Rosenkrands I, Agger E, Andersen P, Perrie Y
J Pharm Pharmacol
. 2006 Jun;
58(6):787-99.
PMID: 16734980
Vesicular adjuvant systems composing dimethyldioctadecylammonium (DDA) can promote both cell-mediated and humoral immune responses to the tuberculosis vaccine fusion protein in mice. However, these DDA preparations were found to be...